Clinical Trial Evidence The head-to-head comparison comes from the SURPASS clinical trial program for diabetes and SURMOUNT program for weight loss
Some Hashimoto's patients, particularly those with significantly compromised thyroid function, persistent untreated insulin resistance, or cortisol dysregulation, may experience less dramatic results
Nature 405 , 183187 (2000)
"So, when people come off a medication that they need to treat a chronic condition -- which the conditions of overweight and obesity are -- of course, rebound weight gain is possible, if not likely." In the United States, obesity affects nearly 42% of the population and is associated with over $170 billion in medical costs, according to the Centers for Disease Control and Prevention
Sulfur burps are part of that same constellation of digestive side effects, all stemming from the fundamental mechanism of slowed gastric motility
Lipids Health Dis